Blood clots related to the AstraZeneca vaccine rollout have topped 40 after more than half-dozen new cases were reported.
The number of Australians affected by blood clots during the Covid vaccine rollout has now topped 40, according to the federal government’s health body.
AstraZeneca’s Covid-19 vaccine has been linked to 41 reported cases of blood clots. Picture: Getty ImagesThe four confirmed cases were a 40-year-old Victorian woman, being treated in NSW, a 70-year-old Victorian woman, an 82-year-old NSW woman and a 70-year-old man from Queensland. “One of the newly confirmed patients is currently critically unwell and is in intensive care,” the TGA revealed in its latest report.It takes the number of confirmed cases to 31, along with 10 probable cases, all related to the rollout of the AstraZeneca Covid-19 vaccine.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Health staff face rising verbal abuse from frustrated patients waiting for vaccineFrustration with long waiting lists for the AstraZeneca vaccine in regional South Australia leads to GP clinics reporting more verbal abuse from people desperate for the jab.
Read more »
Calls to fast-track Pfizer for Victoria amid ‘phenomenal demand’ for vaccineThe Australian Medical Association is pushing for GPs to be supplied with more COVID-19 vaccines amid a growing Pfizer shortage fuelled by a jump in Victorians getting a jab.
Read more »
Britain in negotiations to buy first vaccine adapted for Beta COVID-19 variantIt came as authorities revealed three-quarters of adults in Britain had received their first COVID-19 vaccine dose, and nearly half the population was fully vaccinated.
Read more »
WHO grants emergency approval to second Chinese COVID-19 vaccineThe WHO has approved the Sinovac Biotech coronavirus vaccine for emergency use, only the second time a non-Western and Chinese vaccine has been given the green light to fight COVID19
Read more »
WHO grants emergency approval to second Chinese COVID-19 vaccineThe World Health Organisation has approved the Sinovac Biotech coronavirus vaccine for emergency use, only the second time a non-Western and Chinese vaccine has been given the green light to fight COVID-19.
Read more »
ASX to rise as iron ore prices surges, market awaits GDP resultAustralian shares are set to rise in morning trade, thanks to a jump in commodity prices — namely oil and iron ore, which should boost energy and mining stocks.
Read more »